The principal provisions remaining within rationalisation and integration provisions relate to the exit from the tissue engineering operation and the closure of the Andover, Massachusetts endoscopy manufacturing facility see Note 5.
Rationalisation and integration and liability provisions are expected to be substantially utilised withinfive years.
Included within the liability provision is $42m 2005 $75m relating to the declination of insurance coverage for macrotextured knee revisions see Note 32.
In addition $112m 2005 $79m has been provided against trade and other debtors relating to this issue.
